Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 7,085 | 7,614 | 7,763 | 2,692 | 536 |
| Income taxes - deferred | 2,732 | -2,370 | -4,041 | -636 | 282 |
| Accounts receivable | 7,591 | 17,586 | 122 | -8,439 | -1,993 |
| Accounts payable and accrued liabilities | -27,140 | -11,909 | -5,254 | 7,578 | 1,721 |
| Other Working Capital | -15,413 | 3,483 | -22,472 | 3,675 | 472 |
| Other Operating Activity | 16,733 | -6,332 | 2,715 | 2,634 | 3,010 |
| Operating Cash Flow | $-8,412 | $8,072 | $-21,167 | $7,504 | $4,028 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -861 | -1,125 | -376 | -105 | 0 |
| Net Acquisitions | -170,855 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -2,672 | -27,445 | -19,367 | -25,782 | -26,164 |
| Sale Of Investment | 47,327 | 128,132 | 81,455 | 49,623 | 100,719 |
| Purchase Sale Intangibles | -1,191 | -10,093 | -2,314 | -522 | -328 |
| Other Investing Activity | 17 | 387 | 76,632 | -167,348 | -1,114 |
| Investing Cash Flow | $-128,235 | $89,856 | $136,030 | $-144,134 | $73,113 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 11,922 | N/A | N/A |
| Debt Repayment | -1,589 | -7,545 | -1,558 | -8,407 | -68 |
| Common Stock Repurchased | -3,736 | -17,954 | -13,311 | -657 | -54,181 |
| Other Financing Activity | 177 | 520 | 73 | 52 | 487 |
| Financing Cash Flow | $-5,148 | $-24,979 | $-2,874 | $-9,012 | $-53,762 |
| Exchange Rate Effect | 293 | -298 | 685 | 785 | 835 |
| Beginning Cash Position | 359,593 | 286,942 | 174,268 | 319,125 | 294,911 |
| End Cash Position | 218,091 | 359,593 | 286,942 | 174,268 | 319,125 |
| Net Cash Flow | $-141,795 | $72,949 | $111,989 | $-145,642 | $23,379 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,412 | 8,072 | -21,167 | 7,504 | 4,028 |
| Capital Expenditure | -2,052 | -11,218 | -2,690 | -627 | -328 |
| Free Cash Flow | -10,464 | -3,146 | -23,857 | 6,877 | 3,700 |